We are live on ! Find out more
P

Pitcairn Portfolio holdings

AUM $1.27B
1-Year Est. Return 23.64%
This Fund
S&P 500
This Quarter Est. Return
+8.21%
1 Year Est. Return
+23.64%
3 Year Est. Return
+111.21%
5 Year Est. Return
+126.49%
10 Year Est. Return
+390.83%
AUM
$1.55B
AUM Growth
+$107M
Cap. Flow
+$4.29M
Cap. Flow %
0.28%
Top 10 Hldgs %
46.66%
Holding
651
New
34
Increased
155
Reduced
400
Closed
26

Sector Composition

Rank Sector Weight
1 Consumer Staples 24.71%
2 Technology 13.77%
3 Healthcare 8.43%
4 Financials 7.42%
5 Consumer Discretionary 5.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UBER icon
151
Uber
UBER
$140B
$1.5M 0.1%
35,699
-3,328
-9% -$143K
SYK icon
152
Stryker
SYK
$122B
$1.48M 0.1%
5,529
-51
-0.9% -$13.4K
CLX icon
153
Clorox
CLX
$11.3B
$1.47M 0.09%
8,448
+1,475
+21% +$246K
DPZ icon
154
Domino's
DPZ
$10.7B
$1.47M 0.09%
2,598
+706
+37% +$359K
CRKN
155
DELISTED
Crown Electrokinetics Corp. Common Stock
CRKN
0
PWR icon
156
Quanta Services
PWR
$98.1B
$1.46M 0.09%
12,763
-1,524
-11% -$176K
EEM icon
157
iShares MSCI Emerging Markets ETF
EEM
$28.6B
$1.41M 0.09%
+28,826
New +$1.45M
ALGN icon
158
Align Technology
ALGN
$12B
$1.4M 0.09%
2,137
-148
-6% -$95.2K
TSM icon
159
TSMC
TSM
$2.16T
$1.4M 0.09%
11,637
-30
-0.3% -$3.51K
XOM icon
160
ExxonMobil
XOM
$650B
$1.37M 0.09%
22,375
-756
-3% -$47.3K
CHTR icon
161
Charter Communications
CHTR
$15.6B
$1.37M 0.09%
2,099
-139
-6% -$94.6K
BBWI icon
162
Bath & Body Works
BBWI
$3.9B
$1.36M 0.09%
19,502
-1,570
-7% -$111K
OMCL icon
163
Omnicell
OMCL
$1.81B
$1.36M 0.09%
7,541
-1,604
-18% -$278K
MDT icon
164
Medtronic
MDT
$105B
$1.35M 0.09%
13,066
-1,874
-13% -$217K
VWO icon
165
Vanguard FTSE Emerging Markets ETF
VWO
$119B
$1.35M 0.09%
27,310
+18,027
+194% +$909K
LRCX icon
166
Lam Research
LRCX
$400B
$1.35M 0.09%
18,730
+230
+1% +$14.4K
ACN icon
167
Accenture
ACN
$84.9B
$1.35M 0.09%
3,248
+727
+29% +$265K
IP icon
168
International Paper
IP
$20.1B
$1.34M 0.09%
28,635
-2,803
-9% -$138K
TSN icon
169
Tyson Foods
TSN
$20B
$1.34M 0.09%
15,395
-9
-0.1% -$740
BMY icon
170
Bristol-Myers Squibb
BMY
$126B
$1.33M 0.09%
21,332
-1,277
-6% -$74.9K
VRTX icon
171
Vertex Pharmaceuticals
VRTX
$120B
$1.31M 0.08%
5,988
+4,487
+299% +$873K
LPLA icon
172
LPL Financial
LPLA
$25.9B
$1.31M 0.08%
8,169
-45
-0.5% -$7.43K
AON icon
173
Aon
AON
$76B
$1.29M 0.08%
4,295
-91
-2% -$27.3K
CSX icon
174
CSX Corp
CSX
$98.1B
$1.29M 0.08%
34,295
-57
-0.2% -$2.01K
BKNG icon
175
Booking.com
BKNG
$134B
$1.29M 0.08%
13,425
-1,000
-7% -$94.8K

Similar funds

Pitcairn's Q4 2021 Portfolio in Review

As of Q4 2021, Pitcairn held 651 positions worth $1.55B, up 7.4% from $1.45B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Pitcairn's Q4 2021 filing shows 34 new, 155 increased, 400 reduced and 26 closed positions. Its largest new stake was iShares Core US Aggregate Bond ETF: 39,116 shares worth $4.46M. The largest sale was iShares Russell 3000 ETF, an estimated $4.88M.

By sector, the portfolio is most concentrated in Consumer Staples at 25% of assets, up from 24% a quarter earlier, followed by Technology and Healthcare.

  • Pitcairn's largest Q4 2021 buy was iShares Core US Aggregate Bond ETF: 39,116 shares worth $4.46M.
  • Pitcairn added most to SPDR Gold Trust in Q4 2021, an estimated $4.07M increase.
  • Pitcairn's biggest Q4 2021 reduction was iShares Russell 3000 ETF, cutting an estimated $4.88M.
  • Pitcairn fully exited Generac Holdings in Q4 2021, selling an estimated $663K.
  • Pitcairn's ten largest holdings make up 47% of its $1.55B portfolio in Q4 2021.
  • Pitcairn opened 34 new positions and closed 26 in Q4 2021.
  • Pitcairn's portfolio value rose 7.4% quarter-over-quarter to $1.55B.

Based on Pitcairn's 13F filing for Q4 2021, filed 14 Feb 2022.